Skip to main content
. 2020 Jun 17;21(12):4312. doi: 10.3390/ijms21124312

Figure 1.

Figure 1

Effect of FDA-_approved DMT on brain atrophy. DMT: Disease modifying treatment. FTY: Fingolimod, TER: Teriflunomide, DMF: Dimethylfumarate, SIP: Siponimod, CLAD: Cladribine, GA: Glatiramer acetate, INF: Interferons, OCR: Ocrelizumab, NTZ: Natalizumab, ALEM: Alemtuzumab, WML: white matter loss, GML: gray matter loss, BVL: brain volume loss.